NCT04493385 The Hepatitis C Transplant Collaborative
| NCT ID | NCT04493385 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor Research Institute |
| Condition | Transplant; Failure, Heart |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2019-09-16 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2019-09-16 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Eligibility Criteria
Inclusion Criteria: 1. Recipient of a proven HCV NAT+ donor heart. 2. Re-transplant patients will be included. Exclusion Criteria: 1\. Multi-organ transplantation
Contact & Investigator
Shelley A Hall, MD FACC
PRINCIPAL INVESTIGATOR
BSWRI
Frequently Asked Questions
Who can join the NCT04493385 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Transplant; Failure, Heart. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04493385 currently recruiting?
Yes, NCT04493385 is actively recruiting participants. Contact the research team at Joost.Felius@BSWHEALTH.ORG for enrollment information.
Where is the NCT04493385 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT04493385 clinical trial?
NCT04493385 is sponsored by Baylor Research Institute. The principal investigator is Shelley A Hall, MD FACC at BSWRI. The trial plans to enroll 500 participants.